BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: de Windt T, Niemansburg S, Vonk L, van Delden J, Roes K, Dhert W, Saris D, Bredenoord A. Ethics in musculoskeletal regenerative medicine; guidance in choosing the appropriate comparator in clinical trials. Osteoarthritis and Cartilage 2019;27:34-40. [DOI: 10.1016/j.joca.2018.08.022] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 Bunnik EM, de Jongh D, Massey E. Ethics of Early Clinical Trials of Bio-Artificial Organs. Transpl Int 2022;35:10621. [DOI: 10.3389/ti.2022.10621] [Reference Citation Analysis]
2 Peat G, Thomas MJ. Osteoarthritis year in review 2020: epidemiology & therapy. Osteoarthritis Cartilage 2021;29:180-9. [PMID: 33242603 DOI: 10.1016/j.joca.2020.10.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 25] [Article Influence: 1.5] [Reference Citation Analysis]
3 Spinner DS, Faulkner EC, Carroll MC, Ringo MC, Joines JW. Regenerative Medicine and Cell Therapy in Orthopedics—Health Policy, Regulatory and Clinical Development, and Market Access. Techniques in Orthopaedics 2019;34:224-43. [DOI: 10.1097/bto.0000000000000413] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]